ERBB2 and breast cancer: GRP78 was shown to be elevated in all breast cancer subtypes [ERα, human epidermal growth factor receptor-2 (ERBB1; HER2) amplified, and triple negative] when compared with the normal surrounding breast tissue, indicating a critical role for GRP78 in driving breast tumorigenesis (11).